Literature DB >> 29569118

Arterial stiffness and left ventricular performance in elderly patients with persistent atrial fibrillation.

Stefano Fumagalli1, Marta Migliorini2, Simone Pupo2, Irene Marozzi2, Serena Boni2, Alessandra Scardia2, Alessandro Masi2, Anna T Roberts2, Luigi Padeletti3,4, Niccolò Marchionni2.   

Abstract

BACKGROUND: The prevalence of atrial fibrillation (AF) and arterial stiffness (AS) increases with age. AIMS: To evaluate if AS is correlated to longitudinal strain (LS), a marker of left ventricular (LV) function, in elderly AF patients with preserved ejection fraction (EF) undergoing external cardioversion.
METHODS: AS was measured using the cardio-ankle vascular index (CAVI), LS was calculated from echocardiographic data of three consecutive cardiac cycles.
RESULTS: We enrolled 38 patients (age 76 ± 8 years; men 60.5%; EF 65 ± 7%). LS and CAVI were, respectively, - 17.7 ± 3.7% and 9.7 ± 1.3. Multivariate analysis showed that LV performance was inversely related to height (p < 0.001) and to the presence of AF-related symptoms (p = 0.008). LS grew with increasing values of CAVI (p = 0.038).
CONCLUSIONS: In elderly AF patients with preserved systolic function, LV performance is directly associated with AS. This link could influence atrium remodeling and the incidence of arrhythmia relapse.

Entities:  

Keywords:  Arterial stiffness; Atrial fibrillation; CAVI; Elderly; Electric cardioversion; Longitudinal strain

Mesh:

Year:  2018        PMID: 29569118     DOI: 10.1007/s40520-018-0935-8

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  2 in total

1.  Recurrence of atrial fibrillation after pulmonary vein isolation in dependence of arterial stiffness.

Authors:  T Shchetynska-Marinova; M Kranert; S Baumann; V Liebe; A Grafen; S Gerhards; S Rosenkaimer; I Akin; M Borggrefe; A L Hohneck
Journal:  Neth Heart J       Date:  2021-11-24       Impact factor: 2.380

2.  Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation.

Authors:  Tomasz Zapolski; Anna Kamińska; Tomasz Kocki; Andrzej Wysokiński; Ewa M Urbanska
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.